The immunological and virological response in human immunodeficiency virus type-1 (HIV-1) infected Indian individuals on HAART therapy: a one-year follow up study
Kannangai, R.; Ramalingam, S.; Vijayakumar, T.S.; Vincent, A.A.; Abraham, O.C.; Subramanian, S.; Rupali, P.; Mathai, D.; Jesudason, M.V.; Sridharan, G.
Indian Journal of Medical Microbiology 21(4): 274-276
2003
ISSN/ISBN: 0255-0857 PMID: 17643043 Document Number: 558756
Currently, antiretroviral therapy has become more affordable even in developing countries and it is being used in India. Fifteen HIV-1 infected individuals, who were on highly active antiretroviral therapy (HAART), were followed up for an average period of one year. The plasma viral load and CD4+ T cell estimation done at mean intervals of 5 months and 11 months after initiation of therapy showed a good response to therapy in 14 (93%) individuals.
Document emailed within 1 workday
Related Documents
Jallow, S.; Alabi, A.; Sarge-Njie, R.; Peterson, K.; Whittle, H.; Corrah, T.; Jaye, A.; Cotten, M.; Vanham, G.; McConkey, S.J.; Rowland-Jones, S.; Janssens, W. 2009: Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants Journal of Clinical Microbiology 47(7): 2200-2208Varella, R.B.ão.; Ferreira, S.B.ía.; Castro, M.ár.B.d.; Tavares, M.D.; Zalis, M.G. 2008: Prevalence of resistance-associated mutations in human immunodeficiency virus type 1-positive individuals failing HAART in Rio de Janeiro, Brazil Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 12(5): 380-384
Heikinheimo, O.; Lehtovirta, P.äi.; Aho, I.; Ristola, M.; Paavonen, J. 2011: The levonorgestrel-releasing intrauterine system in human immunodeficiency virus-infected women: a 5-year follow-up study American Journal of Obstetrics and Gynecology 204(2): 126.E1-4
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Shahapur, P.R.; Bairy, I.; Shivananda, P.G. 2005: Effect of "HAART" on CD4+ T lymphocyte counts in HIV seropositive south-Indian individuals--a follow up study Indian Journal of Pathology and Microbiology 48(2): 270-272
Machado, A.A.; Hirsch, I.; Figueiredo, J.F.; Martinez, R.; de Freitas-Silva, G.; Chermann, J.C.; Covas, D.T. 1996: Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1) Revista da Sociedade Brasileira de Medicina Tropical 29(6): 615-617
Diaz, A.; Ten, A.; Marcos, H.; Gutiérrez, G.; González-García, J.; Moreno, S.; Barrios, A.M.ía.; Arponen, S.; Portillo, Ál.; Serrano, R.; García, M.T.; Pérez, J.é L.; Toledo, J.; Royo, M.C.; González, G.; Izquierdo, A.; Viloria, L.J.; López, I.; Elizalde, L.áz.; Martínez, E.; Castrillejo, D.; Aranguren, R.; Redondo, C.; Diez, M. 2015: Factors determining irregular attendance to follow-up visits among human immunodeficiency virus patients: results of the hospital survey of patients infected with human immunodeficiency virus Enfermedades Infecciosas y Microbiologia Clinica 33(5): 324-330
Chitra, P.; Bakthavatsalam, B.; Palvannan, T. 2011: Beta-2 microglobulin as an immunological marker to assess the progression of human immunodeficiency virus infected patients on highly active antiretroviral therapy Clinica Chimica Acta; International Journal of Clinical Chemistry 412(11-12): 1151-1154
Kiertiburanakul, S.; Sungkanuparph, S.; Rattanasiri, S.; Manosuthi, W.; Vibhagool, A.; Thakkinstian, A. 2006: Virological and immunological responses of efavirenz-based HAART regimen initiated in HIV-infected patients at CD4 < 100 versus CD4 > or = 100 cells/mm3 Journal of the Medical Association of Thailand 89(9): 1381-1387
Wenger, N.S.; Kusseling, F.S.; Beck, K.; Shapiro, M.F. 1994: Sexual behavior of individuals infected with the human immunodeficiency virus. The need for intervention Archives of Internal Medicine 154(16): 1849-1854
Swaminathan, S.; Padmapriyadarsini, C.; Ponnuraja, C.; Sumathi, C.H.; Rajasekaran, S.; Amerandran, V.A.; Reddy, M.; Deivanayagam, C.N. 2007: Miliary tuberculosis in human immunodeficiency virus infected patients not on antiretroviral therapy: clinical profile and response to shortcourse chemotherapy Journal of Postgraduate Medicine 53(4): 228-231
Martin, J.B.; Easley-Shaw, T.; Collins, C. 1991: Use of selected vitamin and mineral supplements among individuals infected with human immunodeficiency virus Journal of the American Dietetic Association 91(4): 476-478
Palacios, G.C.; Montalvo, M.S.; Fraire, M.I.; Leon, E.; Alvarez, M.T.; Solorzano, F. 2008: Audiologic and vestibular findings in a sample of human immunodeficiency virus type-1-infected Mexican children under highly active antiretroviral therapy International Journal of Pediatric Otorhinolaryngology 72(11): 1671-1681
Schorling, S.R.; Kortinga, H.C.; Froschb, M.; Mühlschlegel, F.A. 2000: The role of Candida dubliniensis in oral candidiasis in human immunodeficiency virus-infected individuals Critical Reviews in Microbiology 26(1): 59-68
Chen, S-Liang.; Zhao, H-Ru.; Li, X-Mei.; Zhang, Y-Qi.; Jin, G-Sheng.; Zhao, C-Ying.; Zhang, Y-Ping.; Bai, G-Yi.; Li, B-Jun.; Liang, L.; Chen, Z-Qiang.; Hui, Y-Liang.; Liu, F-Bao.; Xu, Z-Xian.; Zhu, J-Guo.; Mao, Y-Rong. 2009: Retrospective cohort study on the rate of mother-to-child transmission among mothers infected with human immunodeficiency virus type 1 through blood transfusion Zhonghua Liu Xing Bing Xue Za Zhi 30(6): 564-566
Farquhar, C.; Wamalwa, D.; Selig, S.; John-Stewart, G.; Mabuka, J.; Majiwa, M.; Sutton, W.; Haigwood, N.; Wariua, G.; Lohman-Payne, B. 2009: Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination Pediatric Infectious Disease Journal 28(4): 295-299
Siraprapasiri, P.; Tharavichitkul, E.; Suntornpong, N.; Tovanabutra, C.; Meennuch, E.; Panboon, P.; Swangsilpa, T.; Siraprapasiri, T. 2016: Effects of Radiation Therapy on Immunological and Virological Status in HIV-Infected Cancer Patients in Thailand: a Multicenter Prospective Study Journal of the Medical Association of Thailand 99(Suppl 2): S9-16
Norrgren, H.; da Silva, Z.; Biague, A.; Andersson, Sören.; Biberfeld, G. 2003: Clinical progression in early and late stages of disease in a cohort of individuals infected with human immunodeficiency virus-2 in Guinea-Bissau Scandinavian Journal of Infectious Diseases 35(4): 265-272
Shakoor, Z. 2003: Serial evaluation of percentage of activated T-lymphocytes in peripheral blood of human immunodeficiency virus infected individuals as a prognostic marker Saudi Medical Journal 24(6): 632-636
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94